Moscow, Russia

Leonid Gaydukov

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2010-2015.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Rehovot, IL (2010)
  • Moscow, RU (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Leonid Gaydukov: Innovator in PON Enzymes

Introduction

Leonid Gaydukov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of PON enzymes. With a total of 2 patents, his work has implications for various applications in research and medicine.

Latest Patents

Gaydukov's latest patents include innovations related to PON polypeptides and polynucleotides. These patents describe isolated polynucleotides and polypeptides encoded therefrom, which include mutated PON enzymes. These enzymes exhibit increased, modified, or substantially the same substrate specificity compared to their respective wild-type PON. Additionally, the patents provide kits and methods utilizing these enzymes, showcasing their potential for practical applications.

Career Highlights

Throughout his career, Gaydukov has been associated with Yeda Research and Development & Co. Ltd. His work has been instrumental in advancing the understanding and application of PON enzymes in various scientific fields.

Collaborations

Some of his notable coworkers include Dan S Tawfik and Amir Aharoni, who have collaborated with him on various projects related to his research.

Conclusion

Leonid Gaydukov's contributions to the field of biotechnology through his patents on PON enzymes highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence research and development in this important area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…